Skip to content

Find our latest news, stories and press releases

Delivering long-term value for our stakeholders

Explore career opportunities and more

Impacting health for humanity

  1. Home/
  2. Media Center/
  3. Press releases /
  4. Financial

Financial

Johnson & Johnson Reports 2020 First-Quarter Results:

· Sales of $20.7 billion reflecting strong growth of 3.3%, operational growth of 4.8%* and adjusted operational growth of 5.6%*, inclusive of the overall estimated negative impact of the COVID-19 pandemic · EPS of $2.17 increased 56.1%; adjusted EPS of $ 2.30 increased 9.5%* · Dividend increase of 6.3% announced · Long term fundamentals remain intact; 2020 guidance lowered to reflect COVID-19 impact and related investments

Johnson & Johnson Reports 2019 Fourth-Quarter and Full Year Results

· 2019 Fourth-Quarter Sales of $20.7 Billion reflecting growth of 1.7%, operational growth of 2.6%* and adjusted operational growth of 3.4%* · 2019 Full-Year Sales of $82.1 Billion reflecting growth of 0.6%, operational growth of 2.8%* and adjusted operational growth of 4.5%* · 2019 Fourth-Quarter EPS of $1.50 increased 33.9%; adjusted EPS of $1.88 decreased 4.6%* · 2019 Full-Year EPS of $5.63 increased 0.4%; adjusted EPS of $8.68 increased 6.1%* · Company projects continued sales and earnings growth in 2020 guidance

Results Have Been Updated in Accordance with the Form 8-K Filed on October 23, 2019 Johnson & Johnson Reports 2019 Third-Quarter Results

· Sales of $20.7 billion reflecting growth of 1.9%, operational growth of 3.2%* and adjusted operational growth of 5.2%* · EPS of $0.66 decreased (54.2)%; adjusted EPS of $2.12 increased 3.4% · Company increasing Full Year Sales and EPS guidance due to strong performance